Danaher Co. (NYSE:DHR) Shares Bought by Chevy Chase Trust Holdings LLC

Chevy Chase Trust Holdings LLC grew its stake in Danaher Co. (NYSE:DHRGet Rating) by 1.3% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 490,544 shares of the conglomerate’s stock after purchasing an additional 6,178 shares during the quarter. Chevy Chase Trust Holdings LLC owned approximately 0.07% of Danaher worth $126,704,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of DHR. Schechter Investment Advisors LLC raised its stake in Danaher by 12.4% during the third quarter. Schechter Investment Advisors LLC now owns 6,777 shares of the conglomerate’s stock worth $1,751,000 after purchasing an additional 749 shares during the period. XML Financial LLC grew its holdings in Danaher by 46.2% during the 3rd quarter. XML Financial LLC now owns 4,956 shares of the conglomerate’s stock worth $1,280,000 after acquiring an additional 1,565 shares in the last quarter. AIA Group Ltd grew its holdings in Danaher by 62.1% during the 3rd quarter. AIA Group Ltd now owns 5,719 shares of the conglomerate’s stock worth $1,477,000 after acquiring an additional 2,192 shares in the last quarter. Vaughan Nelson Investment Management L.P. lifted its position in shares of Danaher by 40.6% during the 3rd quarter. Vaughan Nelson Investment Management L.P. now owns 696,672 shares of the conglomerate’s stock worth $179,943,000 after buying an additional 201,056 shares during the last quarter. Finally, Empirical Finance LLC lifted its position in shares of Danaher by 20.2% during the 3rd quarter. Empirical Finance LLC now owns 15,518 shares of the conglomerate’s stock worth $4,008,000 after buying an additional 2,604 shares during the last quarter. Institutional investors and hedge funds own 77.26% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts recently commented on the stock. Credit Suisse Group downgraded shares of Danaher from an “outperform” rating to a “neutral” rating and reduced their price target for the company from $315.00 to $300.00 in a research report on Thursday, January 5th. Robert W. Baird reduced their target price on shares of Danaher from $321.00 to $309.00 in a report on Wednesday. Deutsche Bank Aktiengesellschaft initiated coverage on shares of Danaher in a report on Tuesday, December 13th. They issued a “buy” rating and a $310.00 target price on the stock. JPMorgan Chase & Co. reduced their target price on shares of Danaher from $350.00 to $315.00 and set an “overweight” rating on the stock in a report on Friday, October 21st. Finally, Barclays upped their target price on shares of Danaher from $277.00 to $290.00 and gave the company an “overweight” rating in a report on Tuesday. Three research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $310.29.

Insider Transactions at Danaher

In related news, EVP Joakim Weidemanis sold 9,508 shares of the business’s stock in a transaction dated Monday, November 28th. The shares were sold at an average price of $266.60, for a total transaction of $2,534,832.80. Following the completion of the sale, the executive vice president now owns 71,498 shares of the company’s stock, valued at approximately $19,061,366.80. The sale was disclosed in a legal filing with the SEC, which is available through this link. In other news, EVP Joakim Weidemanis sold 9,508 shares of the company’s stock in a transaction that occurred on Monday, November 28th. The stock was sold at an average price of $266.60, for a total transaction of $2,534,832.80. Following the completion of the transaction, the executive vice president now directly owns 71,498 shares of the company’s stock, valued at $19,061,366.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Matthew Mcgrew sold 18,935 shares of the firm’s stock in a transaction that occurred on Friday, November 11th. The stock was sold at an average price of $274.72, for a total value of $5,201,823.20. Following the completion of the sale, the chief financial officer now directly owns 29,634 shares in the company, valued at approximately $8,141,052.48. The disclosure for this sale can be found here. In the last three months, insiders have sold 38,538 shares of company stock worth $10,424,284. 11.20% of the stock is currently owned by insiders.

Danaher Price Performance

DHR opened at $268.00 on Wednesday. The company has a market capitalization of $195.09 billion, a P/E ratio of 30.01, a PEG ratio of 2.23 and a beta of 0.82. The company has a 50-day moving average of $266.13 and a 200-day moving average of $268.98. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.38 and a current ratio of 1.78. Danaher Co. has a 1-year low of $233.71 and a 1-year high of $303.82.

Danaher (NYSE:DHRGet Rating) last announced its quarterly earnings data on Tuesday, January 24th. The conglomerate reported $2.87 earnings per share for the quarter, beating the consensus estimate of $2.45 by $0.42. The firm had revenue of $8.37 billion during the quarter, compared to analyst estimates of $7.90 billion. Danaher had a return on equity of 18.33% and a net margin of 21.65%. Danaher’s quarterly revenue was up 2.7% on a year-over-year basis. During the same period in the previous year, the company earned $2.69 earnings per share. Equities analysts expect that Danaher Co. will post 10.55 EPS for the current fiscal year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 27th. Shareholders of record on Friday, December 30th will be issued a dividend of $0.25 per share. The ex-dividend date of this dividend is Thursday, December 29th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 0.37%. Danaher’s dividend payout ratio (DPR) is 11.05%.

About Danaher

(Get Rating)

Danaher Corp. operates as a medical company, which designs, manufactures, and markets professional, medical, industrial, and commercial products and services. It operates through the following segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, to understand the causes of disease, identify new therapies and test new drugs and vaccines.

Featured Articles

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.